146 related articles for article (PubMed ID: 34653100)
1. Association of the Geriatric Nutritional Risk Index With the Survival of Patients With Non-Small Cell Lung Cancer After Nivolumab Therapy.
Karayama M; Inoue Y; Yoshimura K; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suda T
J Immunother; 2022 Feb-Mar 01; 45(2):125-131. PubMed ID: 34653100
[TBL] [Abstract][Full Text] [Related]
2. Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy.
Karayama M; Inoue Y; Yasui H; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inui N; Suda T
BMC Pulm Med; 2021 Dec; 21(1):409. PubMed ID: 34895201
[TBL] [Abstract][Full Text] [Related]
3. [A Prognostic Model of Elderly Patients with Non-small Cell Lung Cancer
Based on Geriatric Nutritional Risk Index].
Zhang X; Xiong Y; Xu A
Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):497-506. PubMed ID: 37653013
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of the geriatric nutritional risk index among patients with previously treated advanced non-small cell lung cancer who subsequently underwent immunotherapy.
Sonehara K; Tateishi K; Araki T; Komatsu M; Yamamoto H; Hanaoka M
Thorac Cancer; 2021 May; 12(9):1366-1372. PubMed ID: 33710780
[TBL] [Abstract][Full Text] [Related]
5. Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive-stage disease small cell lung cancer: Results from a randomized controlled trial.
Lee GW; Go SI; Kim DW; Kim HG; Kim JH; An HJ; Jang JS; Kim BS; Hahn S; Heo DS
Thorac Cancer; 2020 Jan; 11(1):62-71. PubMed ID: 31707767
[TBL] [Abstract][Full Text] [Related]
6. Preoperative Geriatric Nutritional Risk Index: A predictive and prognostic factor in patients with pathological stage I non-small cell lung cancer.
Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
Surg Oncol; 2017 Dec; 26(4):483-488. PubMed ID: 29113668
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for progression-free survival in non-small cell lung cancer patients receiving nivolumab based on performance status.
Adachi Y; Tamiya A; Taniguchi Y; Enomoto T; Azuma K; Kouno S; Inagaki Y; Saijo N; Okishio K; Atagi S
Cancer Med; 2020 Feb; 9(4):1383-1391. PubMed ID: 31880861
[TBL] [Abstract][Full Text] [Related]
8. Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab.
Fujiwara R; Yuasa T; Yamamoto S; Fujiwara M; Takemura K; Urasaki T; Oki R; Komai Y; Oguchi T; Numao N; Yonese J
Nutr Cancer; 2023; 75(2):670-677. PubMed ID: 36448767
[TBL] [Abstract][Full Text] [Related]
9. Geriatric Nutritional Risk Index as a Prognostic Factor of Patients with Non-Small Cell Lung Cancer: A Meta-Analysis.
Yang M; Liu Z; Li G; Li B; Li C; Xiao L; Zhou J
Horm Metab Res; 2022 Sep; 54(9):604-612. PubMed ID: 36070746
[TBL] [Abstract][Full Text] [Related]
10. A Multivariable Regression Model-based Nomogram for Estimating the Overall Survival of Patients Previously Treated With Nivolumab for Advanced Non-small-cell Lung Cancer.
Tamiya A; Tamiya M; Go H; Inoue T; Kunimasa K; Nakahama K; Taniguchi Y; Shiroyama T; Isa SI; Nishino K; Kumagai T; Suzuki H; Hirashima T; Atagi S; Shintani A; Imamura F
Anticancer Res; 2020 Aug; 40(8):4229-4236. PubMed ID: 32727749
[TBL] [Abstract][Full Text] [Related]
11. Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small-Cell Lung Cancer.
Haratani K; Hayashi H; Chiba Y; Kudo K; Yonesaka K; Kato R; Kaneda H; Hasegawa Y; Tanaka K; Takeda M; Nakagawa K
JAMA Oncol; 2018 Mar; 4(3):374-378. PubMed ID: 28975219
[TBL] [Abstract][Full Text] [Related]
12. Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort Study.
Lang D; Huemer F; Rinnerthaler G; Horner A; Wass R; Brehm E; Akbari K; Granitz M; Hutarew G; Kaiser B; Greil R; Lamprecht B
Target Oncol; 2019 Dec; 14(6):707-717. PubMed ID: 31654203
[TBL] [Abstract][Full Text] [Related]
13. Low Geriatric Nutritional Risk Index as a Poor Prognostic Marker for Second-Line Pembrolizumab Treatment in Patients with Metastatic Urothelial Carcinoma: A Retrospective Multicenter Analysis.
Etani T; Naiki T; Sugiyama Y; Nagai T; Iida K; Noda Y; Shimizu N; Tasaki Y; Mimura Y; Okada T; Banno R; Kubota H; Hamamoto S; Ando R; Kawai N; Yasui T
Oncology; 2020; 98(12):876-883. PubMed ID: 32862183
[TBL] [Abstract][Full Text] [Related]
14. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study.
Shoji F; Miura N; Matsubara T; Akamine T; Kozuma Y; Haratake N; Takamori S; Katsura M; Takada K; Toyokawa G; Takenaka T; Yamazaki K; Okamoto T; Takeo S; Maehara Y
Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):389-394. PubMed ID: 29049803
[TBL] [Abstract][Full Text] [Related]
16. The Geriatric Nutritional Risk Index as a Prognostic Factor in Patients with Advanced Non-Small-Cell Lung Cancer.
Peng SM; Yu N; Ren JJ; Xu JY; Chen GC; Yang JR; Li ZN; Du HZ; Li DP; Zhang YS; Qin LQ
Nutr Cancer; 2021; 73(11-12):2832-2841. PubMed ID: 33356605
[TBL] [Abstract][Full Text] [Related]
17. The Geriatric Nutritional Risk Index and Prognostic Nutritional Index Predict the Overall Survival of Advanced Non-Small Cell Lung Cancer Patients.
Matsuura S; Morikawa K; Ito Y; Kubota T; Ichijo K; Mochizuki E; Akiyama N; Uehara M; Harada M; Tsukui M; Koshimizu N
Nutr Cancer; 2022; 74(5):1606-1613. PubMed ID: 34431441
[TBL] [Abstract][Full Text] [Related]
18. Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy.
Gataa I; Mezquita L; Rossoni C; Auclin E; Kossai M; Aboubakar F; Le Moulec S; Massé J; Masson M; Radosevic-Robin N; Alemany P; Rouanne M; Bluthgen V; Hendriks L; Caramella C; Gazzah A; Planchard D; Pignon JP; Besse B; Adam J
Eur J Cancer; 2021 Mar; 145():221-229. PubMed ID: 33516050
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the geriatric nutritional risk index and the prognostic nutritional index in determining survival outcome in patients with non-small cell lung cancer undergoing surgical resection: A cohort study.
An S; Han GY; Eo W; Kim DH; Lee S
Medicine (Baltimore); 2022 Nov; 101(45):e31591. PubMed ID: 36397370
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Nivolumab in Previously Treated Patients With Non-Small-cell Lung Cancer: Real World Experience in Argentina.
Martin C; Lupinacci L; Perazzo F; Bas C; Carranza O; Puparelli C; Kowalyszyn R; Magri I; Varela M; Richardet E; Vera K; Foglia S; Jerez I; Aman E; Martinengo G; Batagelj E; Dri A; Pilnik N; Roa GM; Mando P; Tsou F; Recondo G; Cayol F; Flores M; Sena S; Bagnes C; Waisberg FD; Minatta JN; Rizzo M
Clin Lung Cancer; 2020 Sep; 21(5):e380-e387. PubMed ID: 32213298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
